{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-075387","form_type":"8-K","ticker":"RZLT","cik":"0001509261","company_name":"Rezolute, Inc.","filed_at":"2024-06-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.742759+00:00","generated_at":"2026-06-01T00:59:11.710145+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Rezolute raises ~$67M through public offering and concurrent private placement","bullets":["Underwriters exercised over-allotment option for 1,786,589 shares at $4.00 each.","Total offering: 13,036,589 shares plus pre-funded warrants for 3.75M shares; gross proceeds ~$67M.","Concurrent private placement of 1.5M shares at $4.00/share for ~$6M in additional gross proceeds.","Net proceeds will fund clinical R&D (RZ358 for hyperinsulinism) and working capital.","Jefferies and Cantor acted as joint book-running managers for the public offering."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-075387","json":"https://secwatch.observer/filing/0001104659-24-075387.json","markdown":"https://secwatch.observer/filing/0001104659-24-075387.md","text":"https://secwatch.observer/filing/0001104659-24-075387.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1509261/000110465924075387/0001104659-24-075387-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1509261/000110465924075387/tm2418270d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T00:59:11.710145+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}